Skip to content

FDA approves first three-drug fixed-dose tablet for PEPFAR use

Modelling study predicts efficacy and cost-effectiveness of HIV treatment after single-dose nevirapine

Kaletra receives EU marketing approval; developing countries registration 'moving forward'

Warning issued over bleeding within the skull in patients taking tipranavir

Fatty liver prevalence high with HIV/HCV coinfection: 'use ddI or d4T cautiously'

Small number of individuals with drug-resistant HIV having unprotected sex

US activists 'applaud' darunavir (Prezista, TMC114) pricing

Two generic HIV drugs approved for children by FDA

Malnourishment at time HIV treatment is started equals much poorer survival